Int. Journal of Generic Drugs
Locum International Press
Issues Numbers 1 - 8
Each volume contains eight issues per year
The International Journal of Generic Drugs
publishes articles reviews and papers on all aspects of Generic and Innovative
Drug Development from preformulation to aspects of regulatory strategy.
Emphasis is placed on the US exposure of the Generic Drug Industry with
special reference to the on-time development of ANDA
The Chemistry, Manufacture and Controls (CMC)
section of NDA development cover hands-on nuts-and- bolts
developmental issues that vary across the full drug development spectrum
from documentation requirements, excipients specifications, development
(pre-to-final) formulation, scale-up, analytical, cleaning and process
validation protocols necessary for the entire
drug development process.
The overall objective in generic / CMC drug development is to get the
newly developed product to the market place on time.
The Journal attempts to clarify and simplify development and regulatory
issues to achieve this crucial objective.
80 - 95 pp illustrated
b/w & color
Subscription - Print
$1499.00 - Print Edition (Single-user
or first time
user / airmail edition worldwide)
$1899.00 - Corporate single license single pharma campus - (Print)
$1999.00 - Corporate multiple-user license - (Print / Electronic edition
maximizes distribution and readership for multiple pharma campus). Price
excludes international shipping and insurance - Note: Registered
shipping charges change per country.
QUICK ORDER PROCESS
The Journals in print format are ordered via Locum International for international
subscriptions and confirmed by e-mail